Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Association between lipodystrophy and leptin in human immunodeficiency virus-1-infected children receiving lopinavir/ritonavir-based therapy.

Resino S, Palladino C, Lorente R, Micheloud D, Bellón JM, Larru B, Gutiérrez MD, de José MI, Polo R, Muñoz-Fernández MA; Spanish Group of Pediatric HIV Infection..

Pediatr Infect Dis J. 2010 Aug;29(8):774-7. doi: 10.1097/INF.0b013e3181db741b.

PMID:
20375850
2.

Long-term response to highly active antiretroviral therapy in human immunodeficiency virus and hepatitis C virus coinfected children: 6 years of follow-up.

Micheloud D, Jensen J, Bellón JM, Gonzalez R, Mellado MJ, Navarro ML, Muñoz-Fernández MA, Resino S; Spanish Group of Pediatric HIV Infection..

Pediatr Infect Dis J. 2007 Nov;26(11):1061-4.

PMID:
17984818
3.

Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children.

Micheloud D, Jensen J, Bellón JM, Gurbindo D, de José MI, Moreno D, Ramos JT, Muñoz-Fernández MA, Resino S; Spanish Group of Pediatric HIV Infection..

Pediatr Infect Dis J. 2007 Sep;26(9):846-9.

PMID:
17721385
4.

Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children.

Resino S, Resino R, Maria Bellón J, Micheloud D, Gutiérrez MD, de José MI, Ramos JT, Fontelos PM, Ciria L, Muñoz-Fernández MA; Spanish Group of Pediatric HIV Infection..

Clin Infect Dis. 2006 Jul 15;43(2):243-52. Epub 2006 Jun 9.

PMID:
16779753

Supplemental Content

Loading ...
Support Center